Conor Benn has failed a drugs test but is still set to face off against Chris Eubank Jnr on Saturday.
The Daily Mail reported that the 26-year-old had tested positive for trace amounts of banned substance clomifene, a drug usually used to treat infertility in women but can increase testosterone in men. Clomifene is prohibited by the World Anti-Doping Agency, and the news had initially thrown the fight on October 8 into grave uncertainty.
However, it has now been confirmed that the test took place in September and Benn has since passed a doping control test by UK Anti-Doping Agency, meaning the fight at London's O2 Arena will still go ahead.
A statement from promoters Matchroom read: "We have been made aware that a random anti-doping test for Conor Benn conducted by the Voluntary Anti-Doping Association returned an adverse analytical finding for trace amounts of a fertility drug. The B sample has yet to be tested, meaning that no rule violation has been confirmed.
"Indeed, Mr Benn has not been charged with any rule violation, he is not suspended, and he remains free to fight. Mr Benn has since passed a doping control test conducted by the UK Anti-Doping Agency, the anti-doping authority to which the British Board of Boxing Control has delegated its doping control testing for the bout. Mr Benn has passed all doping control tests conducted by UKAD.
"Both fighters have taken medical and legal advice, are aware of all relevant information, and wish to proceed with the bout this Saturday."
The highly-anticipated bout is set to take place nearly 30 years after the second of two iconic fights between the pair's fathers, Nigel Benn and Chris Eubank, and is believed to be worth a six-figure fee to the pair.
